The prevalence of nephrotoxicity associated with polymyxins has an increasing trend through the years and reaches up to 74% in colistin-treated patients and 46% in polymyxin B-treated patients in the literature [ 13 ].
← all excerpts
Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins.
1
—
—